title: Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel.
authors.affiliation: ZEG - Berlin, Berlin, Germany. k.heinemann@zeg-berlin.de
authors.forename: Klaas
authors.initials: K
authors.lastname: Heinemann
authors.forename: Lothar A J
authors.initials: LA
authors.lastname: Heinemann
mesh_terms: D000736:Androstenes / Q000008:administration & dosage / Q000009:adverse effects*; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects; D005260:Female; D006801:Humans; D016912:Levonorgestrel / Q000008:administration & dosage / Q000009:adverse effects*; D000451:Mineralocorticoid Receptor Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D018570:Risk Assessment; D054556:Venous Thromboembolism / Q000139:chemically induced*
chemical_list: D000736:Androstenes; D003276:Contraceptives, Oral; D003280:Contraceptives, Oral, Synthetic; D000451:Mineralocorticoid Receptor Antagonists; D016912:Levonorgestrel; C035144:drospirenone